Program Test definition

Program Test means any nucleic acid test used to determine appropriate recipients of Program Products (i) the manufacture, use or sale of which would, absent the license or ownership rights granted to Access hereunder infringe any claim included in the Program Patent Rights or the ILI Patent Rights, or (ii) which was developed, modified or improved hereunder.
View Source

Examples of Program Test in a sentence

  • If a Certified Product displays one or more of the Marks, it means that a representative sample of the Certified Product met the requirements of the ▇▇▇ Certification Program Test Plan.

  • Claiming Unit means part of an LGA such as a public agency or subcontractor to an LGA to 10 perform MAA, whose costs can be segregated as a separate budget unit.

  • Further, Licensee covenants, represents, and warrants that, to the best of Licensee’s knowledge, Licensee’s Certified Product meets the applicable requirements of the ▇▇▇ Certification Program Test Plan.

  • Licensee shall make no claims or indications that Alliance endorses Licensee or its products or services, except that Licensee may use the ▇▇▇▇(s) to indicate that its Certified Product meets the ▇▇▇ Certification Program Test Plan, pursuant to the terms of this Agreement.

  • Licensee may use the ▇▇▇▇(s) solely during the term of this Agreement, solely in accordance with the terms and conditions of this Agreement and the ▇▇ ▇▇▇ Certification ▇▇▇▇ Usage Guidelines (defined and discussed below), and solely to indicate that Licensee’s Certified Product(s) is compliant with the ▇▇▇ Certification Program Test Plan.

  • The Work shall be deemed to be substantially complete when (i) construction is sufficiently complete, in accordance with the Contract Documents, so that the Station may begin operating pursuant to Program Test Authority under FCC rules using the facilities proposed in the Construction Permit and (ii) all permits, modifications of permits, authorizations and licenses necessary to operate such facilities have been obtained.

  • Licensee may not use the ▇▇▇▇(s) in any manner that indicates or represents anything other than the fact that Licensee’s Certified Products are in compliance with the ▇▇▇ Certification Program Test Plan.

  • Contractor shall: (i) submit the Summary Space-Based Network Acceptance Test Report at least 24 hours prior to conducting the SBN Acceptance Test review, and (ii) conduct the SBN Acceptance Test review within three (3) days of completing the SBN Acceptance Test, and (iii) provide MSV with a Certificate of Acceptance, all (i) – (iii) in accordance with Section 2.2.13 of Exhibit A, L-Band Space Based Network Statement of Work, the SBN Program Test Plan and this Article 10.

  • The procedures shall be developed in conformance with the IOT Plan of the Satellite Program Test Plan and prescribe acceptance criteria for verifying Satellite operation during early orbit operations after successful injection into mission orbit.

  • If Contractor does not receive a Certificate of Completion, Contractor shall correct or repair each non-conformance with all deliberate speed and resubmit such Satellite for additional testing in accordance with applicable requirements of Exhibit C, L-Band SBN System Test Plan and Exhibit D, Satellite Program Test Plan, and conduct a second SPSR.

Related to Program Test

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Screening Test means a drug or alcohol test which uses a method of analysis allowed by the Minnesota Drug and Alcohol Testing in the Workplace Act to be used for such purposes.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Biomarker testing means the analysis of an Insured’s tissue, blood, or other biospecimen for the presence of a Biomarker. "Biomarker testing" includes but is not limited to single-analyte tests, multi-plex panel tests, protein expression, whole exome, whole genome, and whole transcriptome sequencing.